Rice Hall James & Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.15M | Sell |
|
|||||
|
2025
Q2 | $2.74M | Buy |
|
|||||
|
2025
Q1 | $5.23M | Sell |
|
|||||
|
2024
Q4 | $11.8M | Sell |
|
|||||
|
2024
Q3 | $15.8M | Buy |
|
|||||
|
2024
Q2 | $13.1M | Sell |
|
|||||
|
2024
Q1 | $25.4M | Sell |
|
|||||
|
2023
Q4 | $14.2M | Buy |
|
|||||
|
2023
Q3 | $7.84M | Sell |
|
|||||
|
2023
Q2 | $12.4M | Buy |
|
|||||
|
2023
Q1 | $10.6M | Sell |
|
|||||
|
2022
Q4 | $11.6M | Buy |
|
|||||
|
2022
Q3 | $13.7M | Sell |
|
|||||
|
2022
Q2 | $18.8M | Buy |
|
|||||
|
2022
Q1 | $18.1M | Buy |
|
|||||
|
2021
Q4 | $12.1M | Sell |
|
|||||
|
2021
Q3 | $21.3M | Sell |
|
|||||
|
2021
Q2 | $23M | Buy |
|
|||||
|
2021
Q1 | $22.4M | Sell |
|
|||||
|
2020
Q4 | $33M | Sell |
|
|||||
|
2020
Q3 | $24.4M | Buy |
|
|||||
|
2020
Q2 | $18.7M | Buy |
|
|||||
|
2020
Q1 | $13.5M | Buy |
|